Moreover, in the whole cohort, we found a prognostic effect for each of the GEX signatures BC proliferation, Hypoxia, Mast cells, and the GEX of AR, ESR1, and PGR, even after adjustment for established prognostic factors. The gene discussed is AR; the disease is breast cancer.